title: Heparin and cilazapril together inhibit injury-induced intimal hyperplasia.
abstract: Both heparin and the angiotensin converting enzyme inhibitor cilazapril inhibit intimal thickening in rat carotid arteries injured by the passage of a balloon catheter. The purpose of this study was to determine if combinations of the two drugs were more effective than either drug alone and whether the effect could be accounted for by inhibition of smooth muscle cell proliferation. Heparin (0.1-0.3 mg/kg/hr) administered by continuous intravenous infusion with or without cilazapril (0-25 mg/kg/day p.o.) produced a dose-dependent inhibition of smooth muscle accumulation at 14 days after rat carotid ballooning. At the lower doses, the inhibitory effects of heparin and cilazapril were additive when the drugs were used together. This overall effect on growth was reflected in decreased smooth muscle cell proliferation at 2 and 7 days. A 7-day course of heparin combined with cilazapril, a regimen that might be applicable in the clinical setting, produced an 80% inhibition of intimal thickening at 28 days. These results provide evidence that heparin and cilazapril together might prove to be more effective than either drug alone in the control of intimal hyperplasia after arterial injury.
authors.affiliation: Department of Surgery, University of Washington School of Medicine, Seattle 98195.
authors.forename: A W
authors.initials: AW
authors.lastname: Clowes
authors.forename: M M
authors.initials: MM
authors.lastname: Clowes
authors.forename: S C
authors.initials: SC
authors.lastname: Vergel
authors.forename: R K
authors.initials: RK
authors.lastname: Müller
authors.forename: J S
authors.initials: JS
authors.lastname: Powell
authors.forename: F
authors.initials: F
authors.lastname: Hefti
authors.forename: H R
authors.initials: HR
authors.lastname: Baumgartner
mesh_terms: D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology*; D000818:Animals; D002339:Carotid Arteries / Q000187:drug effects / Q000473:pathology; D002455:Cell Division / Q000187:drug effects; D017315:Cilazapril; D004357:Drug Synergism; D004730:Endothelium, Vascular / Q000187:drug effects* / Q000473:pathology; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology*; D006965:Hyperplasia; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects* / Q000473:pathology; D011724:Pyridazines / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D011919:Rats, Inbred Strains
chemical_list: D000806:Angiotensin-Converting Enzyme Inhibitors; D011724:Pyridazines; D017315:Cilazapril; D006493:Heparin